Surgical Ablation for Atrial Fibrillation in Mitral Valve Surgery: Improved Survival and Stroke Risk in US Veterans

Authors

  • John Duggan Division of Cardiothoracic Surgery, Veterans Affairs Medical Center, Washington, D.C. 20422, USA; Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA
  • Alex Peters Division of Cardiothoracic Surgery, Veterans Affairs Medical Center, Washington, D.C. 20422, USA; Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA
  • Sarah Halbert Division of Cardiothoracic Surgery, Veterans Affairs Medical Center, Washington, D.C. 20422, USA; Department of Surgery, MedStar Georgetown University Hospital, Washington, D.C. 20007, USA
  • Jared Antevil Division of Cardiothoracic Surgery, Veterans Affairs Medical Center, Washington, D.C. 20422, USA; Department of Surgery, Walter Reed National Military Medical Center, Bethesda, MD 20814, USA; Department of Surgery, George Washington University School of Medicine and Health Sciences, Washington, D.C. 20052, USA
  • Gregory D. Trachiotis Division of Cardiothoracic Surgery, Veterans Affairs Medical Center, Washington, D.C. 20422, USA; Department of Surgery, George Washington University School of Medicine and Health Sciences, Washington, D.C. 20052, USA

DOI:

https://doi.org/10.59958/hsf.6715

Keywords:

atrial fibrillation, ablation, mitral valve, MAZE, left atrial appendage occlusion

Abstract

Background: Surgical ablation for atrial fibrillation (AF) is strongly recommended in patients undergoing mitral valve (MV) surgery but is underutilized. Left atrial appendage occlusion (LAAO) in patients with AF undergoing cardiac surgery is a matter of debate, and it is not clear which patients derive long-term benefit. This issue has not been investigated in United States Veterans. Methods: We performed a retrospective review of 1289 patients with pre-operative AF who underwent MV surgery between 2010–2020. Patients were grouped based on whether their procedure included ablation and LAAO, LAAO without ablation, or neither. Cox proportional hazard models, adjusted for covariates, were used to calculate risk for stroke, myocardial infarction (MI), and death based on intervention. Results: Ablation was performed in 645/1289 (50.0%) of patients and LAAO without ablation was performed in 186/1289 (14.4%) patients. Mean follow-up was 4.1 ± 3.1 years. Patients who underwent ablation had a 62% lower long-term risk of stroke (0.38, 95% CI: 0.22–0.67, p < 0.001) and 20% lower long-term mortality risk (adjusted hazard ratios (aHR) 0.80, 95% CI: 0.66–0.95, p = 0.012), but no difference in risk of MI (aHR 0.67, 95% CI: 0.38–1.16, p = 0.15). LAAO was not associated with differences in long-term risk of stroke, MI, or death. There were no differences in perioperative complications between groups. Conclusions: In veterans with AF undergoing MV surgery, ablation was inversely and independently associated with long-term stroke risk and long-term mortality, with no increased risk of perioperative complications. LAAO did not reduce long-term stroke risk.

References

Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge. International Journal of Stroke: Official Journal of the International Stroke Society. 2021; 16: 217–221.

Ad N, Suri RM, Gammie JS, Sheng S, O'Brien SM, Henry L. Surgical ablation of atrial fibrillation trends and outcomes in north america. The Journal of Thoracic and Cardiovascular Surgery. 2012; 144: 1051–1060.

Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978; 28: 973–977.

Kamel H, Okin PM, Elkind MSV, Iadecola C. Atrial Fibrillation and Mechanisms of Stroke: Time for a New Model. Stroke. 2016; 47: 895–900.

Badhwar V, Rankin JS, Damiano RJ Jr, Gillinov AM, Bakaeen FG, Edgerton JR, et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. The Annals of Thoracic Surgery. 2017; 103: 329–341.

Cox JL, Ad N, Palazzo T. Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. The Journal of Thoracic and Cardiovascular Surgery. 1999; 118: 833–840.

Cox JL, Schuessler RB, D'Agostino HJ Jr, Stone CM, Chang BC, Cain ME, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. The Journal of Thoracic and Cardiovascular Surgery. 1991; 101: 569–583.

Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. The Annals of Thoracic Surgery. 1996; 61: 755–759.

Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M, et al. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. The New England Journal of Medicine. 2021; 384: 2081–2091.

Piccini JP, Sievert H, Patel MR. Left atrial appendage occlusion: rationale, evidence, devices, and patient selection. European Heart Journal. 2017; 38: 869–876.

Khan SU, Khan MZ, Alkhouli M. Reader's Comments: Trends in the Utilization of Left Atrial Appendage Exclusion in the United States. The American Journal of Cardiology. 2020; 126: 106–107.

About VHA. US Department of Veterans Affairs: Veterans Health Administration Web site. 2022. Available at: https://www.va.gov/health/aboutvha.asp#:~:text=VHA%20Leadership,than%209%20million%20enrolled%20Veterans (Accessed: 30 September 2022).

National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee to Review the Health Effects in Vietnam Veterans of Exposure to Herbicides (Eleventh Biennial Update). Veterans and Agent Orange: Update 11 (2018). Washington (DC): National Academies Press (US). 2018. Available at: https://www.ncbi.nlm.nih.gov/books/NBK535904/ (Accessed: 19 December 2022).

Clausen AN, Clarke E, Phillips RD, Haswell C, VA Mid-Atlantic MIRECC Workgroup, Morey RA. Combat exposure, posttraumatic stress disorder, and head injuries differentially relate to alterations in cortical thickness in military Veterans. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2020; 45: 491–498.

Sachs-Ericsson N, Joiner TE, Cougle JR, Stanley IH, Sheffler JL. Combat Exposure in Early Adulthood Interacts with Recent Stressors to Predict PTSD in Aging Male Veterans. The Gerontologist. 2016; 56: 82–91.

Agha Z, Lofgren RP, VanRuiswyk JV, Layde PM. Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use. Archives of Internal Medicine. 2000; 160: 3252–3257.

Khuri SF, Daley J, Henderson W, Hur K, Hossain M, Soybel D, et al. Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. Annals of Surgery. 1999; 230: 414–432.

Massarweh NN, Kaji AH, Itani KMF. Practical Guide to Surgical Data Sets: Veterans Affairs Surgical Quality Improvement Program (VASQIP). JAMA Surgery. 2018; 153: 768–769.

Davis CL, Pierce JR, Henderson W, Spencer CD, Tyler C, Langberg R, et al. Assessment of the reliability of data collected for the Department of Veterans Affairs national surgical quality improvement program. Journal of the American College of Surgeons. 2007; 204: 550–560.

Gammie JS, Haddad M, Milford-Beland S, Welke KF, Ferguson TB, Jr, O'Brien SM, et al. Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. The Annals of Thoracic Surgery. 2008; 85: 909–914.

Saint LL, Damiano RJ Jr, Cuculich PS, Guthrie TJ, Moon MR, Munfakh NA, et al. Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery. The Journal of Thoracic and Cardiovascular Surgery. 2013; 146: 1072–1077.

Raanani E, Albage A, David TE, Yau TM, Armstrong S. The efficacy of the Cox/maze procedure combined with mitral valve surgery: a matched control study. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2001; 19: 438–442.

Chevalier P, Leizorovicz A, Maureira P, Carteaux JP, Corbineau H, Caus T, et al. Left atrial radiofrequency ablation during mitral valve surgery: a prospective randomized multicentre study (SAFIR). Archives of Cardiovascular Diseases. 2009; 102: 769–775.

Blomström-Lundqvist C, Johansson B, Berglin E, Nilsson L, Jensen SM, Thelin S, et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). European Heart Journal. 2007; 28: 2902–2908.

Doukas G, Samani NJ, Alexiou C, Oc M, Chin DT, Stafford PG, et al. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. JAMA. 2005; 294: 2323–2329.

Cheng DCH, Ad N, Martin J, Berglin EE, Chang BC, Doukas G, et al. Surgical ablation for atrial fibrillation in cardiac surgery: a meta-analysis and systematic review. Innovations (Philadelphia, Pa.). 2010; 5: 84–96.

Louagie Y, Buche M, Eucher P, Schoevaerdts JC, Gerard M, Jamart J, et al. Improved patient survival with concomitant Cox Maze III procedure compared with heart surgery alone. The Annals of Thoracic Surgery. 2009; 87: 440–446.

Lee CH, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW. Left atrial appendage resection versus preservation during the surgical ablation of atrial fibrillation. The Annals of Thoracic Surgery. 2014; 97: 124–132.

Gillinov AM, Gelijns AC, Parides MK, DeRose JJ Jr, Moskowitz AJ, Voisine P, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. The New England Journal of Medicine. 2015; 372: 1399–1409.

Mehaffey JH, Krebs E, Hawkins RB, Charles EJ, Tsutsui S, Kron IL, et al. Variability and Utilization of Concomitant Atrial Fibrillation Ablation During Mitral Valve Surgery. The Annals of Thoracic Surgery. 2021; 111: 29–34.

Yao X, Gersh BJ, Holmes DR Jr, Melduni RM, Johnsrud DO, Sangaralingham LR, et al. Association of Surgical Left Atrial Appendage Occlusion With Subsequent Stroke and Mortality Among Patients Undergoing Cardiac Surgery. JAMA. 2018; 319: 2116–2126.

Ando M, Funamoto M, Cameron DE, Sundt TM 3rd. Concomitant surgical closure of left atrial appendage: A systematic review and meta-analysis. The Journal of Thoracic and Cardiovascular Surgery. 2018; 156: 1071–1080.e2.

Tsai YC, Phan K, Munkholm-Larsen S, Tian DH, La Meir M, Yan TD. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis. European Journal of Cardio-thoracic Surgery: Official Journal of the European Association for Cardio-thoracic Surgery. 2015; 47: 847–854.

Lee R, McCarthy PM, Wang EC, Vaduganathan M, Kruse J, Malaisrie SC, et al. Midterm survival in patients treated for atrial fibrillation: a propensity-matched comparison to patients without a history of atrial fibrillation. The Journal of Thoracic and Cardiovascular Surgery. 2012; 143: 1341–1351.

Kim HJ, Chang DH, Kim SO, Kim JK, Kim K, Jung SH, et al. Left atrial appendage preservation versus closure during surgical ablation of atrial fibrillation. Heart (British Cardiac Society). 2022; 108: 1864–1872.

Published

2024-02-05

How to Cite

Duggan, J., Peters, A. ., Halbert, S. ., Antevil, J., & Trachiotis, G. D. (2024). Surgical Ablation for Atrial Fibrillation in Mitral Valve Surgery: Improved Survival and Stroke Risk in US Veterans. The Heart Surgery Forum, 27(2), E094-E101. https://doi.org/10.59958/hsf.6715

Issue

Section

Article